Institutions / Foresite Capital Management VI LLC
Foresite Capital Management VI LLC
CIK 2013341 · Institutionalso an insider · as of Dec 31, 2025
Portfolio value
$330.84M
Positions
12
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| CG Oncology, Inc. | $92.24M | 27.9% |
| RAPT Therapeutics, Inc. | $52.92M | 16.0% |
| Alumis Inc.ALMS | $41.46M | 12.5% |
| Centessa Pharmaceuticals plc | $34.11M | 10.3% |
| Verastem, Inc. | $24.20M | 7.3% |
| Denali Therapeutics Inc. | $16.51M | 5.0% |
| Natera, Inc. | $15.43M | 4.7% |
| Agios Pharmaceuticals, Inc. | $14.43M | 4.4% |
| Kymera Therapeutics, Inc. | $11.39M | 3.4% |
| Atai Beckley N.V. | $11.25M | 3.4% |
| Corvus Pharmaceuticals, Inc. | $10.64M | 3.2% |
| Hinge Health, Inc. | $6.27M | 1.9% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.
Insider transactions
Also files Forms 3 / 4 / 5